Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisViral hepatitis and hepatocellular carcinomaTyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adultsMultidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaSurveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisManagement of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's LawDiagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-AnalysisReview article: the management of autoimmune hepatitis beyond consensus guidelinesNon-invasive diagnosis of focal liver lesions: an individualized approachBiomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and chinaHepatocellular carcinoma: a reviewModel-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineCost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Management strategies for hepatocellular carcinoma: old certainties and new realities.In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft.Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusElevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.In vivo application of short-lag spatial coherence imaging in human liver.Current role of ultrasound for the management of hepatocellular carcinomaDiagnosis of hepatocellular carcinoma.Review article: percutaneous treatment of hepatocellular carcinoma.The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisationDes-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinomaDetailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.Progression of liver cirrhosis to HCC: an application of hidden Markov model.Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.Cost-effectiveness of liver cancer screening in adults at high risk for liver cancer in the republic of Korea.Recent developments in the first detection of hepatocellular carcinomaLaser ablation for small hepatocellular carcinoma.Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysisRETRACTED: Gene expression profiling analysis of hepatocellular carcinomaRole of ultrasonography in the staging of gastrointestinal neoplasms.PKM2 regulates Gli1 expression in hepatocellular carcinoma.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.
P2860
Q21144594-A06DF8BD-5E52-4B46-8882-6DCBE57E7F3CQ21245597-5597714B-E463-4EE6-B55F-566DE9E0CAE7Q24187730-38C6F7E9-6273-40B4-9BC3-1CF15CE693A6Q24635267-C2B2B661-FF18-45FA-A057-902EA506D9DFQ26740317-CCB3B631-3E00-487F-AAC6-625C7E903F7DQ26797581-D76CAD9B-1C8C-419F-8935-9FDF429D2AE2Q26863560-1E26E7A6-31FA-4948-930D-8F54B8A89469Q26864272-21F094E4-D283-47AE-8F71-9D638DC2855FQ26999766-9FBAB731-2477-465F-85DA-BD0B104A73C4Q27003291-532D1B71-12E0-4E51-8803-84218D779A72Q28069290-264727CF-0402-4FE2-8E4E-95728E3CB442Q28087569-1287F366-57C4-465E-94E2-612598807576Q30151390-DEF3B42D-A1B0-4370-B1E3-DA9E7C410D9EQ30244651-37B7B187-36F9-42B3-A563-EF69CF5415A5Q30252143-B1CE462D-A69E-4A8D-AFC8-44AEE5FE6930Q30372076-2D31964B-4BDE-48A4-B8B7-BBA4CCDFF3C4Q30375738-676BC271-77DF-463A-8276-4C7609938211Q30422199-14DFB8DB-8C36-4E78-BA24-AB4E1A66F948Q30429663-6F33ADC9-1290-41D2-BFB0-3759B5E7C962Q30442495-ABB22E95-5E14-4199-BA74-BF2497CA0F5DQ30488974-98BA4D00-2132-420B-8387-4F9C9C5D98BAQ30490554-EB450B07-6A3E-498C-AF8B-E90A6254596AQ30942931-AA5D75DF-7210-4930-82FB-2D3CEFD8A95BQ33272872-8C404800-B865-497A-BBA2-3B703E8ECA3DQ33405296-A62EDA13-F0E1-42C3-998A-2B7EA5E7E5BFQ33576986-EED4F251-DA78-4F93-8733-CA110AA8DC8FQ33642229-6F22793F-5015-4778-A66C-3E929DC738D1Q33643368-E88A5FDD-14B4-4124-A13A-00D9A10EEA78Q33685277-239590E3-9062-474E-8D6D-FD6134F21091Q33686038-4F4392CA-3A5B-463D-A3F8-BDD47B1E685CQ33860546-4D28D365-5233-42A7-A9D1-37F45C1638D6Q33866389-F4F1E5AA-0162-4702-8CB2-56692226A9C1Q34043444-6ACDABF7-32AE-4CC8-9182-B3A61B348998Q34055894-DF1C09F6-7E6A-4DD5-8DC5-CA1CA719574BQ34108430-E8B12BFF-A465-4526-AFD5-9EF8D650320FQ34189361-EB702BA4-C896-4FEA-808E-F45E61F41DD3Q34253636-CDD9951C-B637-4951-BFF0-3F088D2E33C7Q34277255-7BC26049-B8B4-4067-838B-0E2B8F720518Q34293185-9C549AAF-B518-4303-97BA-55664618A12EQ34409128-37306EF4-9378-4B2E-84A1-DF4F0A0F0391
P2860
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Surveillance programme of cirr ...... a cost effectiveness analysis.
@ast
Surveillance programme of cirr ...... a cost effectiveness analysis.
@en
type
label
Surveillance programme of cirr ...... a cost effectiveness analysis.
@ast
Surveillance programme of cirr ...... a cost effectiveness analysis.
@en
prefLabel
Surveillance programme of cirr ...... a cost effectiveness analysis.
@ast
Surveillance programme of cirr ...... a cost effectiveness analysis.
@en
P2093
P2860
P356
P1433
P1476
Surveillance programme of cirr ...... a cost effectiveness analysis
@en
P2093
P2860
P304
P356
10.1136/GUT.48.2.251
P407
P577
2001-02-01T00:00:00Z